Search
for
Sort by
Research 781–810 of 1000+
- Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
- Targets to treat androgen excess in polycystic ovary syndrome
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Alopecia - the search for novel agents continues
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- Managing hair loss
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Janus Kinase inhibitors in dermatology: a review
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors
- JAK inhibitors and alopecia areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Therapeutic Effect of Rumex japonicus Houtt. on DNCB-Induced Atopic Dermatitis-Like Skin Lesions in Balb/c Mice and Human Keratinocyte HaCaT Cells
- Therapeutic Androgen Receptor Ligands
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- Paracrine Secreted Frizzled-Related Protein 4 Inhibits Melanocytes Differentiation in Hair Follicle
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Stress Inhibits Hair Growth in Mice by Induction of Premature Catagen Development and Deleterious Perifollicular Inflammatory Events via Neuropeptide Substance P-Dependent Pathways
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation